Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer

Amrubicin has been demonstrated to be beneficial in the treatment of patients with relapsed small cell lung cancer (SCLC). The aim of the present study was to evaluate whether there is a significant difference in the efficacy of amrubicin between patients with relapsed SCLC who were previously treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Kasajima, Masashi, Igawa, Satoshi, Ishihara, Mikiko, Otani, Sakiko, Takakura, Akira, Yokoba, Masanori, Kubota, Masaru, Sasaki, Jiichiro, Katagiri, Masato, Masuda, Noriyuki
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403529/
https://ncbi.nlm.nih.gov/pubmed/28454315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5662
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars